InMed Pharmaceuticals Inc. (INM) DCF Valuation

InMed Pharmaceuticals Inc. (INM) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

InMed Pharmaceuticals Inc. (INM) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment strategies with the InMed Pharmaceuticals Inc. (INM) DCF Calculator! Explore authentic financial data, adjust growth projections and expenses, and instantly observe how these adjustments affect the intrinsic value of InMed Pharmaceuticals Inc. (INM).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue .0 .0 .8 2.9 3.2 4.1 5.2 6.7 8.5 10.9
Revenue Growth, % 0 0 0 279.61 11.18 27.79 27.79 27.79 27.79 27.79
EBITDA -6.0 -6.8 -12.0 -7.5 -4.9 -.8 -1.0 -1.3 -1.7 -2.2
EBITDA, % 100 100 -1584.07 -261.92 -153.64 -20 -20 -20 -20 -20
Depreciation .1 .1 .4 .4 .4 2.2 2.9 3.7 4.7 6.0
Depreciation, % 100 100 46.98 14.41 13.15 54.91 54.91 54.91 54.91 54.91
EBIT -6.1 -6.9 -12.3 -7.9 -5.3 -.8 -1.0 -1.3 -1.7 -2.2
EBIT, % 100 100 -1631.05 -276.33 -166.79 -20 -20 -20 -20 -20
Total Cash 4.1 5.1 4.3 6.2 4.6 4.1 5.2 6.7 8.5 10.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .1 .2 .2
Account Receivables, % 100 100 8.08 6.3 7.67
Inventories .0 -663.4 1.7 1.1 .9 3.0 3.8 4.9 6.2 8.0
Inventories, % 100 100 228.64 39.08 27.06 73.23 73.23 73.23 73.23 73.23
Accounts Payable .7 .5 .8 .4 .4 2.7 3.4 4.4 5.6 7.1
Accounts Payable, % 100 100 107.03 13.16 13.62 65.36 65.36 65.36 65.36 65.36
Capital Expenditure .0 .0 .0 -.1 .0 -.1 -.1 -.1 -.1 -.2
Capital Expenditure, % 100 100 -3.59 -3.91 -0.20212 -1.54 -1.54 -1.54 -1.54 -1.54
Tax Rate, % -0.09258716 -0.09258716 -0.09258716 -0.09258716 -0.09258716 -0.09258716 -0.09258716 -0.09258716 -0.09258716 -0.09258716
EBITAT -6.3 -6.9 -12.3 -7.9 -5.3 -.8 -1.0 -1.3 -1.7 -2.2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -5.5 656.5 -676.9 -7.6 -4.7 -.1 1.1 1.5 1.9 2.4
WACC, % 7.74 7.74 7.74 7.74 7.74 7.74 7.74 7.74 7.74 7.74
PV UFCF
SUM PV UFCF 5.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 2
Terminal Value 42
Present Terminal Value 29
Enterprise Value 34
Net Debt -4
Equity Value 38
Diluted Shares Outstanding, MM 8
Equity Value Per Share 5.04

What You Will Get

  • Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: InMed Pharmaceuticals Inc.’s (INM) financial data pre-filled to enhance your analysis.
  • Automatic DCF Outputs: The template automatically calculates Net Present Value (NPV) and intrinsic value for your convenience.
  • Customizable and Professional: A sleek Excel model that can be tailored to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, verifying strategies, and streamlining your process.

Key Features

  • Real-Life INM Data: Pre-filled with InMed Pharmaceuticals’ historical financials and forward-looking projections.
  • Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures to fit your analysis.
  • Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your customized inputs.
  • Scenario Testing: Create multiple forecast scenarios to examine various valuation outcomes.
  • User-Friendly Design: Intuitive, organized, and suitable for both professionals and newcomers.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review InMed Pharmaceuticals Inc.'s (INM) pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
  5. Step 5: Analyze the outputs and utilize the results for your investment decisions.

Why Choose This Calculator for InMed Pharmaceuticals Inc. (INM)?

  • User-Friendly Interface: Tailored for both newcomers and seasoned professionals.
  • Customizable Inputs: Adjust parameters to suit your specific analysis needs.
  • Real-Time Adjustments: Instantly view changes to InMed's valuation as you modify inputs.
  • Preloaded Data: Comes equipped with InMed's latest financial information for swift evaluations.
  • Relied Upon by Experts: A go-to tool for investors and analysts aiming for well-informed decisions.

Who Should Use This Product?

  • Pharmaceutical Students: Explore drug development processes and apply your knowledge using real-world data.
  • Researchers: Integrate advanced models into your studies or clinical research.
  • Investors: Validate your investment strategies and assess valuation scenarios for InMed Pharmaceuticals Inc. (INM).
  • Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech companies.
  • Healthcare Entrepreneurs: Understand how public biotech firms like InMed Pharmaceuticals Inc. (INM) are evaluated in the market.

What the Template Contains

  • Historical Data: Includes InMed Pharmaceuticals Inc.'s (INM) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate InMed Pharmaceuticals Inc.'s (INM) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of InMed Pharmaceuticals Inc.'s (INM) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.